FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
The FDA and CDC are investigating a Salmonella outbreak tied to moringa leaf powder from India. Member’s Mark Super Greens ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...
FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application ...
Sarepta Therapeutics' shares plunged nearly 40% in premarket trading on Tuesday as failure of two of its approved drugs for a ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...
Gov. Hochul has condemned the Trump administration's decision not to fully fund SNAP, calling it "indefensible." ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the ...
Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback